AGIO   $45.53  3.15% Market Closed After Close 45.5 -0.07%

Agios Pharmaceuticals Inc
Total Cash 569.89M
totalCashPerShare 10.017
EBITDA -399.10M
Total Debt 64.62M
quickRatio 9.158
currentRatio 10.092
Total Revenue 31.31M
debtToEquity 9.783
Revenue/Share 0.557
ROA -0.27247998
ROE -0.44922
grossProfits
freeCashflow -223.51M
operatingCashflow -306.59M
earningsGrowth
revenueGrowth 0.284
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -12.28288
profitMargins 0.0
enterpriseValue 1.89B
forwardPE -6.937294
floatShares 50.37M
sharesOutstanding 56.89M
sharesShort 3.28M
sharesShortPriorMonth 2.90M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.04%
Short Ratio help_outline 6.09%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 11.613
Price To Book help_outline 3.62
earningsQuarterlyGrowth
netIncomeToCommon -364.93M
trailingEps -6.50%
forwardEps -6.06%
enterpriseToEbitda -4.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.02 3Q 2024
institutionsCount 299
lastUpdated Oct. 16, 2024, 12:24 p.m.